Symbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.
01 1Symbiotica Speciality Ingredients Sdn Bhd
01 1MOMETASONE FUROATE
01 1Malaysia
01 1Active
01 1Complete
Symbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.
GDUFA
DMF Review : Complete
Rev. Date : 2020-09-09
Pay. Date : 2020-01-31
DMF Number : 26153
Submission : 2012-06-01
Status : Active
Type : II
20
Symbiotica Speciality Ingredients Sdn Bhd, based in Malaysia, is a pharmaceutical company that stands out with its certifications from FDA.
They are recognized for Symbiotica delivers high-quality APIs through advanced R&D, GMP-certified manufacturing, & trusted global pharmaceutical partnerships.
One of their notable products is MOMETASONE FUROATE, with a corresponding US DMF Number 26153.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 09, 2020, and payment made on January 31, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
